Cargando…

Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone

Metabolic hormones stabilize brain reward and motivational circuits, whereas excessive opioid consumption counteracts this effect and may impair metabolic function. Here we addressed the role of metabolic processes in the course of the agonist medication-assisted treatment for opioid use disorder (O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elman, Igor, Howard, Margaret, Borodovsky, Jacob T., Mysels, David, Rott, David, Borsook, David, Albanese, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101411/ https://www.ncbi.nlm.nih.gov/pubmed/32221389 http://dx.doi.org/10.1038/s41598-020-62556-0

Ejemplares similares

Author Correction: Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone
por: Elman, Igor, et al.
Publicado: (2020)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
por: Lund, Ingunn O, et al.
Publicado: (2012)

Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood
por: Leventelis, Christonikos, et al.
Publicado: (2019)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy
por: Pajusco, Benedetta, et al.
Publicado: (2012)

Methadone induces testosterone suppression in patients with opioid addiction
por: Bawor, Monica, et al.
Publicado: (2014)

Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
por: Moinaddini, Fatemeh, et al.
Publicado: (2022)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
por: Aldabergenov, D, et al.
Publicado: (2022)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

The Effects of Methadone and Buprenorphine on Testis of Rats
por: Corsi, Karen F.
Publicado: (2012)

Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
por: Sadek, Joseph, et al.
Publicado: (2022)

Management of opioid addiction with buprenorphine: French history and current management
por: Poloméni, Pierre, et al.
Publicado: (2014)

Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment
por: Casati, Alicia, et al.
Publicado: (2014)

Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study
por: Samaan, Zainab, et al.
Publicado: (2014)

'Diversion’ of methadone or buprenorphine: 'harm’ versus 'helping’
por: Havnes, Ingrid Amalia, et al.
Publicado: (2013)

Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic
por: Chen, Annie Y., et al.
Publicado: (2022)

Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates
por: Rapeli, Pekka, et al.
Publicado: (2011)

Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015)

Methadone, Buprenorphine, and Street Drug Interactions with Antiretroviral Medications
por: Gruber, Valerie A., et al.
Publicado: (2010)

Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
por: Hassan, Rahimah, et al.
Publicado: (2021)

Demographic and Geospatial Analysis of Buprenorphine and Methadone Prescription Rates
por: Peterman, Nicholas J, et al.
Publicado: (2022)

New developments in managing opioid addiction: impact of a subdermal buprenorphine implant
por: Itzoe, MariaLisa, et al.
Publicado: (2017)

Is Buprenorphine-Naloxone Ready for Prime Time in the Treatment of Opioid Addiction in Managed Care?
por: Curtiss, Frederic R.
Publicado: (2008)

Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines
por: Lintzeris, Nicholas, et al.
Publicado: (2018)

Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden
por: Richert, Torkel, et al.
Publicado: (2015)

Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants
por: Moore, Katy, et al.
Publicado: (2019)

Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
por: Zamani, Nasim, et al.
Publicado: (2020)

Strategies for Transfer From Methadone to Buprenorphine for Treatment of Opioid Use Disorders and Associated Outcomes: A Systematic Review
por: Lintzeris, Nicholas, et al.
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Threat Response System: Parallel Brain Processes in Pain vis-à-vis Fear and Anxiety
por: Elman, Igor, et al.
Publicado: (2018)

Mechanisms Underlying Unconscious Processing and Their Alterations in Post-traumatic Stress Disorder: Neuroimaging of Zero Monetary Outcomes Contextually Framed as “No Losses” vs. “No Gains”
por: Elman, Igor, et al.
Publicado: (2020)

The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
por: Wapf, Victoria, et al.
Publicado: (2008)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review
por: Sritapan, Yasmin, et al.
Publicado: (2020)

Prevalence and Characteristics of Chronic Pain in Buprenorphine and Methadone-Maintained Patients
por: Delorme, Jessica, et al.
Publicado: (2021)

Clinical Case Conference: Strategies for Transferring From Methadone to Buprenorphine
por: Hill, Duncan, et al.
Publicado: (2022)

Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices
por: Shan, Xiaoyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_foe2ofvtnj6ac3fp73us5atp50